India and Myanmar held a fifth bilateral meeting on drug control and cooperation, during which New Delhi highlighted issues pertaining to the trafficking of heroin and amphetamine type stimulants (ATS) in the country
India and Myanmar held a fifth bilateral meeting on drug control and cooperation, during which New Delhi highlighted issues pertaining to the trafficking of heroin and amphetamine type stimulants (ATS) in the country. The meeting between Narcotics Control Bureau (NCB), India, and the Central Committee on Drug Abuse Control, Myanmar, was held virtually on Thursday.
The Indian delegation was led by the Director-General Narcotics Control Bureau, Rakesh Asthana, and the Myanmar side was represented by the Commander of the Drug Enforcement Division (DED) and Joint Secretary of the Central Committee for Drug Abuse Control, Pol. Brig. Gen. Win Naing.
Asthana said: "High prevalence of drug abuse in the northeastern states abutting the Myanmar border is a major cause of concern for India. Apart from porosity of the India-Myanmar border, drug trafficking through the maritime route in Bay of Bengal has emerged as a new challenge for both countries."
He added that the NCB has remained committed towards strengthening the existing mechanism of sharing information and assistance with Myanmar, for combating the drug menace in the region.
Meanwhile Pol. Brig. Gen. Win Naing elaborated on the growing threat of the production of yaba tablets (methamphetamine) which has caused a grave concern in the region, even though the cooperation mechanism between Myanmar and India has been enhanced over the past years.
He urged India to develop frequent information exchange on trafficking of drugs and precursor smuggling activities at every level.